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Abstract
Background: In experimental data analysis, bioinformatics researchers increasingly rely on tools that enable the
composition and reuse of scientific workflows. The utility of current bioinformatics workflow environments can be
significantly increased by offering advanced data mining services as workflow components. Such services can
support, for instance, knowledge discovery from diverse distributed data and knowledge sources (such as GO,
KEGG, PubMed, and experimental databases). Specifically, cutting-edge data analysis approaches, such as semantic
data mining, link discovery, and visualization, have not yet been made available to researchers investigating
complex biological datasets.
Results: We present a new methodology, SegMine, for semantic analysis of microarray data by exploiting general
biological knowledge, and a new workflow environment, Orange4WS, with integrated support for web services in
which the SegMine methodology is implemented. The SegMine methodology consists of two main steps. First, the
semantic subgroup discovery algorithm is used to construct elaborate rules that identify enriched gene sets. Then,
a link discovery service is used for the creation and visualization of new biological hypotheses. The utility of
SegMine, implemented as a set of workflows in Orange4WS, is demonstrated in two microarray data analysis
applications. In the analysis of senescence in human stem cells, the use of SegMine resulted in three novel
research hypotheses that could improve understanding of the underlying mechanisms of senescence and
identification of candidate marker genes.
Conclusions: Compared to the available data analysis systems, SegMine offers improved hypothesis generation
and data interpretation for bioinformatics in an easy-to-use integrated workflow environment.
Background
Systems biology aims at system-level understanding of
biological systems, that is, understanding of system
structures, dynamics, control methods, and design meth-
ods [1]. Biologists collect large quantities of data from in
vitro and in vivo experiments with gene expression
microarrays being the most widely used high-throughput
platform [2]. Since the amount of available data exceeds
human analytical capabilities, technologies that help
analyzing and extracting useful information from such
large amounts of data need to be developed and used.
The field of microarray data analysis has shifted
emphasis from methods for identifying individual differ-
entially expressed genes to methods for identifying
differentially expressed gene categories (enriched gene
sets). A gene set is enriched if the member genes are
statistically significantly differentially expressed com-
pared to the rest of the genes. One of the most popular
controlled vocabularies (ontologies) used for over repre-
sentation analysis was developed by the Gene Ontology
(GO) Consortium [3].
A typical approach to gene set enrichment is to per-
form Fisher’s exact test [4] to identify gene sets anno-
tated by the GO ontology terms which are statistically
significantly over-represented. Examples of other
approaches include Gene Set Enrichment Analysis
(GSEA) [5], GSEA-P [6], Parametric Analysis of Gene
s e tE n r i c h m e n t( P A G E )[ 7 ] ,a n do t h e rm e t h o d s[ 8 - 1 1 ] .
A comparison of several software and web tools (Onto-
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formed by Khatri and Draghici [12].
In contrast with the existing gene set enrichment
methods, the SEGS (Search for Enriched Gene Sets)
semantic subgroup discovery algorithm [13], which is a
part of the SegMine methodology, constructs candidate
gene sets as combinations of GO terms, Kyoto Encyclo-
pedia of Genes and Genomes Orthology [14] (KEGG)
terms, and terms describing gene-gene interactions in
the Entrez [15] database. Furthermore, the generalized
variant of SEGS called g-SEGS [16] is not limited to the
domain of systems biology, and allows for semantic sub-
group discovery on any domain using supplied domain
ontologies. One way to construct biologically meaningful
interpretations from a large amount of experimental
data is to present and visualize it using correlation net-
works. A notable example is ONDEX [17], a database
system that combines methods from semantic database
integration and text mining with methods for graph-
based analysis. It can be applied to the interpretation of
gene expression results. Reactome [18], Biocyc [19], Bio-
Layout [20] and MapMan [21] are examples both of
curated knowledge bases of metabolic reactions and
pathways, and of computational tools to aid in the inter-
pretation of microarrays and similar large-scale datasets.
These tools offer powerful techniques for data explora-
tion, but they often are limited to a few types of data
and rely on the user to notice relevant connections. In
contrast, the Biomine system [22], which is an integral
part of SegMine, is a search engine for link discovery
and visualization of heterogeneous biological databases.
Biomine currently integrates and indexes information
from eight major databases (Entrez Gene, UniProt, Gene
Ontology, OMIM, NCBI HomoloGene, InterPro,
STRING, and KEGG), merged into a single large graph.
Moreover, Biomine provides probabilistic graph search
algorithms to automatically extract the most relevant
subgraphs, and can search for links between given query
sets. Due to the complexity of data analysis, bioinforma-
ticians rely more and more on tools that enable compo-
sition and reuse of workflows. Several tools exist to
support creation, management, and execution of
advanced scientific workflows, such as the Taverna
workbench [23], the Weka data mining platform [24],
KNIME [25], Orange [26], the Kepler scientific workflow
system [27], and the Triana problem solving environ-
ment [28]. However, workflow environments originating
from systems biology have virtually no support for
advanced machine learning and data mining techniques,
while data mining tools have very limited abilities for
making use of the available rich resources of systems
biology web services, databases, ontologies and other
resources. In contrast, the Orange4WS (Orange for web
services) knowledge discovery platform, where the
SegMine methodology was implemented, was con-
structed by integrating data mining software with the
wealth of knowledge and services available on the web,
including systems biology resources.
The SegMine methodology and its implementation as
reusable Orange4WS workflows are the main scientific
contributions of this paper. SegMine allows for holistic
interpretation of experimental data in the context of
general biological knowledge available in public data-
bases. The experimental results from two microarray
datasets (a classical acute lymphoblastic leukemia data-
set [29] and a dataset on senescence in mesenchymal
stem cells [30]) show that SegMine subsumes the results
of a state-of-the-art gene set enrichment tool, and can
be instrumental in supporting formulation of new
hypotheses.
To summarize, this paper presents a new microarray
data analysis methodology and its implementation in a
newly developed service-oriented workflow environment.
It substantially advances previous work in the areas of
microarray data analysis [20,21], link discovery and
visualization [17,22], and workflow environments
[23-26].
Results and Discussion
This section describes the key results of the presented
work. The developed methodology is presented first.
Next, the results of the experimental evaluation of the
methodology are presented and discussed. Finally, the
implementation of the working environment, and the
implementation of the methodology itself are described.
The SegMine methodology
The SegMine methodology aids biologists in interpreting
microarray data, in finding groups of genes with seman-
tic descriptions, and in discovering links between them.
This leads to better understanding of the underlying
biological phenomena and may lead to the formation of
new hypotheses, based on the experimental data and
biological knowledge available in public databases.
The methodology is based on semantic subgroup dis-
covery with the SEGS algorithm, which is complemen-
ted by link discovery and visualization using Biomine
services. Several additional steps (e.g. hierarchical clus-
tering, ranking of genes) and features (e.g. resolution of
gene synonyms, graph coloring) have been implemented
to make the proposed methodology operational and
more flexible. A schematic overview of the SegMine
methodology is presented in Figure 1.
Steps of the SegMine methodology
The SegMine methodology for semantic analysis of
microarray data consists of four main steps, which are
outlined below. Note that the first two steps can be par-
tially aligned with the general framework for gene set
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[31].
1. Data preprocessing This step corresponds to the
gene-level statistics and transformation modules of the
enrichment analysis framework [31] and is composed of
three stages.
In the first stage, SegMine takes class-labeled microar-
ray data that are first loaded and validated as input, and
expression fold change (logFC) is computed. At this
point, different options are available for treating
repeated measurements and missing data.
Second, the genes are ranked using the ReliefF [32]
algorithm or Student’s t-test. Note that other gene-level
statistics and methods that result in ranking may also be
used, such as fold change, signal-to-noise ratio, correla-
tion networks or Support Vector Machines [31,33-35].
Third, different filtering options can be applied to
select a subset of genes. As genes with little variability
across samples are often inherently uninteresting, filter-
ing for genes with low |logFC| is generally recom-
mended to reduce background noise. Note that the
suitable |logFC| cutoff point needs to be determined for
each dataset separately. Finally, separation of up- and
down-regulated genes is also supported.
2. Identifying differentially expressed gene sets The
second step in the SegMine methodology includes the
gene set statistics and significance assessment steps from
[31].
The ranked list of genes generated by step one is used
a si n p u tt ot h eS E G Sa l g o r i t h m[ 1 3 ] ,w h i c hd i s c o v e r s
relevant gene groups, described by logical rules formu-
lated as conjunctions of ontology terms from GO,
KEGG and Entrez. The rules semantically explain differ-
entially expressed gene groups in terms of gene func-
tions, components, processes, and pathways as
annotated in biological ontologies.
SEGS has four main components: (1) the background
knowledge (the GO ontology, KEGG pathways annota-
tions, and Entrez interactions), (2) the SEGS hypothesis
language (the GO, KEGG and interaction terms, and
their conjunctions), (3) the hypothesis generation and
pruning procedure utilizing hierarchy relations and solu-
tion space search parameters, and (4) statistical evalua-
tion of the hypotheses. Note that SEGS only makes use
of the is_a and part_of hierarchical relations in GO.
The SEGS algorithm introduces two new operators,
interact() and intersect(), which can lead to discovery of
gene sets that cannot be found by any other currently
available gene set enrichment analysis software. If S is a
gene set and Entrez is a database of gene-gene interac-
tions, then the new interacting gene set INT(S) is
defined as:
INT(S)=

g : ∃g ∈S : ∃Entrez(g,g )

, (1)
where Entrez(g, g’) is a known interaction of genes g
and g’ from the Entrez gene interaction database. Addi-
tionally, let F be a term from the molecular function
Figure 1 An overview of the SegMine methodology.T h ef o u r
main steps of the SegMine methodology: data preprocessing,
Identification of differentially expressed gene sets, clustering of rules
describing differentially expressed gene sets, and link discovery,
graph visualization and exploration. The data preprocesing step (1)
takes normalized microarray data as the input, and results in a
ranked list of genes. Identification of differentially expressed gene
sets (2) is performed by the SEGS algorithm, which makes use of
the GO and KEGG ontologies and Entrez interactions to construct
gene sets using SEGS operators, hierarchy information, and solution
space search parameters. Rules composed of ontology terms
describing gene sets that SEGS found to be statistically significant
according to three enrichment tests are sent to the agglomerative
hierarchical clustering component (3), which enables grouping of
similar and separation of different rules. Finally, link discovery and
graph visualization (4) is provided by Biomine, which can perform
neighbourhood search as well as search for connections between
two query sets. Note that SegMine supports the construction of
Biomine queries composed of individual genes, gene sets, ontology
terms, rules composed of these terms or even whole clusters.
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component branch, P a term from the biological process
branch, and K a KEGG orthology term. Let F’, C’, P’,
and K’, be the sets of genes annotated by these terms.
The new gene set S c a nt h e nb ec o n s t r u c t e da st h e
intersection of the sets of annotated genes:
SF,C,P,K =

g : g ∈ {F ∩C ∩P ∩K }

(2)
The constructed gene sets that are found to satisfy the
specified solution space search parameters must be
tested for potential enrichment. Currently, SEGS incor-
porates three different tests commonly used in gene set
enrichment analysis: Fisher’se x a c tt e s t ,t h eG S E A
method, and parametric analysis of gene set enrichment
(PAGE).
The p-values of all three methods may be combined
into a single value by taking into account user-defined
weights, according to the following formula, which
allows for controlling preferences for enrichment tests:
p =

wi ∗ pi 
wi
(3)
Note that the aggregate p-value is not the p-value in
the classical sense but is only used to identify gene sets
that have small p-values on several tests.
The significance of gene sets is assessed using permu-
tation testing, but other methods for correcting p-values
for multiple hypothesis testing, such as Bonferroni cor-
rection or false discovery rate (FDR), can be applied.
3. Rule clustering The aim of the third step is to reduce
the complexity of the results produced by SEGS. Often,
several groups of rules found by the SEGS algorithm are
composed of very similar gene sets rendering the analy-
sis more difficult due to duplicate information.
Therefore, SegMine incorporates interactive agglom-
erative hierarchical clustering of SEGS rules to simplify
the exploration of large sets of rules, and to provide a
natural summarization of the results. Hierarchical clus-
tering of rules is performed according to the similarity
of gene sets that are found to be significantly enriched.
Several different metrics are available for the computa-
tion of similarities, for example, Euclidean, Manhattan,
Relief and Hamming. Additionally, agglomerative hier-
archical clustering (provided by Orange), supports var-
ious linkage criteria for computing clusters including
Ward’s linkage, complete linkage, single linkage, and
average linkage.
4. Link discovery and graph visualization The last
step of the SegMine methodology is provided by the
Biomine system, which incorporates several public data-
bases into a single large graph. Biomine implements
advanced probabilistic graph search algorithms that can
discover the parts of the graph most relevant to the
given query. An important integral part of Biomine is
the interactive graph visualization component, which
supports one click links to the original data sources.
In the Biomine graph data model, nodes of the graph
correspond to different concepts (such as gene, protein,
domain, phenotype, biological process, tissue), and
semantically labelled edges connect related concepts (e.
g. gene BCHE encodes protein CHLE, which in turn has
the molecular function ‘beta-amyloid binding’). The
main goal of Biomine is to enable the discovery of new,
indirect connections between biological concepts. Bio-
mine evaluates, extracts and visualizes connections
between given nodes.
All components of the results from steps 1-3 can be
used to formulate queries to the Biomine link discov-
ery engine. SegMine supports the construction of
queries composed of individual genes, gene sets, terms
from the GO ontology, KEGG pathways, rules com-
posed of these terms, or even whole clusters of gene
sets, which are then sent to the Biomine query engine.
Biomine is able to find a connecting subgraph between
these elements using other entities from a number of
public biological databases including Entrez Gene, Uni-
Prot, Gene Ontology, OMIM, NCBI HomoloGene,
InterPro, STRING, and KEGG pathways. Links in such
subgraphs help biologists to uncover unexpected indir-
ect relations and biological mechanisms potentially
characteristic for the underlying biological system.
Moreover, subgraphs produced by Biomine also pre-
sent known biological facts, relations, and literature
citations in an organized and structured way. Finally,
Biomine allows addition of experimental results (e.g.,
gene expression logFC values) to subgraphs, which
facilitates the interpretation of discovered links in the
context of experimental results.
Experiments
This section presents two applications of the proposed
methodology and its implementation with experimental
microarray data. Two microarray datasets were used for
the validation and evaluation of the SegMine methodol-
ogy: a well-known dataset from a clinical trial in acute
lymphoblastic leukemia (ALL), and a dataset about
senescence in human mesenchymal stem cells (MSC).
Acute lymphoblastic leukemia
The aim of the first experiment was to validate the Seg-
Mine methodology, and perform a comparative analysis
of the results using the well-known DAVID [36,37] tool
(Database for Annotation, Visualization and Integrated
Discovery). Because DAVID does not provide probabilis-
tic search in large graphs that is provided in SegMine
through Biomine services, only the results of the _rst
step of the SegMine methodology, namely the sets of
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rithm, were used in the comparison.
Experimental setup
Comparative analysis was performed on a well-known
dataset from a clinical trial in acute lymphoblastic leu-
kemia (ALL) [29], which is a typical dataset for medi-
cal research, with several samples available for each
class (95 arrays for B-type cells and 33 arrays for T-
type cells). This dataset serves as an appropriate refer-
ence for such evaluations, as it has also been a model
dataset for other microarray data analysis tools
[8-10,38,39].
In order to enable direct comparison of the results
both tools were set to use the same parameters. The
GO ontology, KEGG pathways and Entrez gene-gene
interaction database (note that the BIND interaction
database was used in DAVID, as DAVID is not able to
use Entrez). were used as the background knowledge.
In DAVID, the broadest ontology terms were filtered
using the GO FAT filter which attempts to filter the
broadest terms (term specificity is based on the number
of child terms). On the other hand, a manually created
list of terms was used in SegMine.
The top 1000 ranked genes from the data were pro-
vided as the input while the remainder (8001) were trea-
ted as the background. The resulting enriched terms
from DAVID and rules of terms from SegMine were fil-
tered according to the corrected p-value of 0.05. Using
DAVID, p-values are obtained with Fisher’se x a c tt e s t
and Bonferroni correction. The p-values in SegMine are
aggregated by combining p-values of Fisher’se x a c tt e s t ,
PAGE and GSEA methods, which are corrected using
permutation testing. All weights for the aggregation of
p-values were equal in our experiments.
As shown in Figures 2 and 3, thirteen terms obtained
by DAVID remained after p-value filtering. On the
other hand, using SegMine, more rules of terms were
found, although only the top 100 are shown. The gene
sets covered by DAVID and SegMine were compared
using the following formula:
vi,j =
|Si ∩ Dj|
|Dj|
(4)
where Si is the set of genes covered by the i-th Seg-
Mine rule, and Dj is the set of genes covered by the j-th
DAVID term, respectively.
The values vi,j Î [0,...,1] indicate how well the j-th
DAVID term is covered by i-th SegMine rule. Note that
the exclusion of general terms in SegMine is of key
importance for the validity of this measure. If some gen-
eral terms were found to be enriched by SegMine,
according to the above formula they could completely
cover gene sets found by DAVID.
Both DAVID and SegMine identified similar enriched
gene sets describing differences in gene expression
between B-ALL and T-ALL cells, such as lymphocyte
differentiation and activation, cell adhesion molecules
and KEGG processes in which lymphocyte-specific
genes play a major role. Almost all significantly enriched
DAVID gene sets were covered by one or more SegMine
rules, with the exception of gene set 6 (lipid biosynthetic
process), which was covered only partially by several
SegMine rules (see Figures 2 and 3). The main advan-
tage of the results produced by SegMine is that by com-
bining ontology terms the description of the regulated
process is more specific. Many GO terms that were
found as enriched by DAVID appear several times in
the result of SegMine in conjunction with interacting
gene sets.
For example, lymphocyte differentiation from the GO
ontology appears in 17 SegMine rules in conjunction
with different GO and KEGG terms. Such rules can be
interpreted as an enrichment of a gene set that includes
n o to n l yg e n e sd e s c r i b e db yt h ef i r s tt e r m( lymphocyte
differentiation) but also interacting genes described by
the second term, for example, Fc gamma R-mediated
phagocytosis.
Additionally, several gene sets obtained by SegMine
were not identified by DAVID (Figure 2), for example,
rules 25, 33, 41 and 43, which describe positive regula-
tion of lymphocyte activation interacting with peptide
binding, leukocyte activation interacting with Tc e l l
receptor complex, positive regulation of leukocyte activa-
tion interacting with phosphoprotein binding and positive
regulation of leukocyte activation interacting with pep-
tide binding. These rules suggest a different regulation
of a set of receptor-interacting genes (or gene products)
in the two different lineages of ALL cells.
T h ec o m p a r i s o ns h o w st h a tS e g M i n ei sa b l et od i s -
cover the same biological knowledge as DAVID. More-
over, SegMine provides more expressive results in the
form of rules, that is, conjunctions of terms. Such rules
describe gene sets that are more specific than gene sets
reported from other gene set enrichment analysis tools
such as DAVID (see Figures 2 and 3), and therefore
more suitable for generation of new (more specific)
hypotheses. They are evaluated with not only one, but
three enrichment tests. Also, the corrected p-values of
the available tests can be combined into a single, aggre-
gated value by specifying custom weights controlling
user preferences for different gene set enrichment tests.
Senescence in stem cells
In the second experiment SegMine was applied to the
analysis of senescence in human mesenchymal stem
cells (MSC). To date, the underlying molecular mechan-
isms or candidate marker genes that could reflect a
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1: antigen processing and presentation, plasma membrane part, Antigen processing and presentation
2: plasma membrane, membrane part, INT['MHC class II protein binding']
3: lymphocyte differentiation, INT['Primary immunodeficiency']
4: antigen processing and presentation, integral to membrane, Antigen processing and presentation
5: Primary immunodeficiency, INT['lymphocyte activation']
6: integral to membrane, INT['MHC class II protein binding']
7: leukocyte differentiation, INT['Primary immunodeficiency']
8: immune response, plasma membrane part, Antigen processing and presentation
9: antigen processing and presentation, membrane part, Antigen processing and presentation
10: integral to membrane, INT['thymic T cell selection']
11: integral to membrane, INT['positive thymic T cell selection']
12: integral to membrane, INT['negative thymic T cell selection']
13: hemopoietic or lymphoid organ development, INT['Primary immunodeficiency']
14: lymphocyte differentiation, INT['Fc gamma R-mediated phagocytosis']
15: lymphocyte activation, INT['T cell receptor complex']
16: plasma membrane part, INT['positive thymic T cell selection']
17: membrane part, INT['positive thymic T cell selection']
18: immune response, Cell adhesion molecules (CAMs), INT['receptor binding']
19: integral to membrane, plasma membrane part, Autoimmune thyroid disease
20: hemopoiesis, INT['Primary immunodeficiency']
21: lymphocyte differentiation, INT['Fc epsilon RI signaling pathway']
22: lymphocyte differentiation, INT['receptor complex']
23: immune response, plasma membrane part, Cell adhesion molecules (CAMs)
24: Primary immunodeficiency, INT['leukocyte activation']
25: positive regulation of lymphocyte activation, INT['peptide binding']
26: plasma membrane, membrane part, Autoimmune thyroid disease
27: Primary immunodeficiency, INT['membrane part']
28: lymphocyte differentiation, INT['organelle membrane']
29: immune response, plasma membrane, integral to membrane, Cell adhesion molecules (CAMs)
30: immune response, Autoimmune thyroid disease
31: immune response, integral to membrane, Antigen processing and presentation, INT['intracellular membrane-bounded organelle']
32: antigen processing and presentation, Antigen processing and presentation
33: leukocyte activation, INT['T cell receptor complex']
34: regulation of T cell activation, membrane part, INT['Chemokine signaling pathway']
35: plasma membrane part, INT['negative thymic T cell selection']
36: membrane part, INT['thymic T cell selection']
37: regulation of T cell activation, INT['non-membrane spanning protein tyrosine kinase activity']
38: regulation of T cell activation, membrane, INT['non-membrane spanning protein tyrosine kinase activity']
39: plasma membrane part, Viral myocarditis, INT['receptor binding']
40: lymphocyte differentiation, INT['growth factor receptor binding']
41: positive regulation of leukocyte activation, INT['phosphoprotein binding']
42: regulation of leukocyte activation, membrane, INT['phosphoprotein binding']
43: positive regulation of leukocyte activation, INT['peptide binding']
44: lymphocyte differentiation, membrane, INT['transmembrane receptor activity']
45: lymphocyte differentiation, plasma membrane, INT['transmembrane receptor activity']
46: leukocyte differentiation, plasma membrane, INT['receptor signaling protein activity']
47: integral to membrane, Type I diabetes mellitus
48: immune response, Antigen processing and presentation
49: immune response, Cell adhesion molecules (CAMs), INT['cytoplasmic part']
50: regulation of T cell activation, plasma membrane, INT['Chemokine signaling pathway']
Figure 2 Comparison of SegMine and DAVID. The first part of the comparison of the results of SegMine and DAVID on the ALL dataset.
Columns are terms found to be enriched by DAVID, while rows are rules of terms found to be enriched by SegMine. Only the first half of the
100 rules of terms obtained by SegMine is shown. All results are statistically significant with p ≤ 0.05. Darker red shades of matrix cells indicate
higher overlapping of corresponding gene sets. Note that rows of the matrix that consist of lightly shaded cells represent gene sets identified as
significantly enriched by SegMine but not by DAVID, e.g., 25, 33, 41 and 43.
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51: regulation of T cell activation, plasma membrane, INT['Natural killer cell mediated cytotoxicity']
52: regulation of T cell activation, INT['dendrite']
53: integral to membrane, plasma membrane part, Cell adhesion molecules (CAMs), INT['antigen processing and presentation']
54: plasma membrane part, INT['negative thymic T cell selection']
55: regulation of T cell activation, plasma membrane, INT['protein kinase activity']
56: regulation of lymphocyte activation, membrane, INT['non-membrane spanning protein tyrosine kinase activity']
57: regulation of T cell activation, INT['phosphatase activity']
58: lymphocyte differentiation, plasma membrane, INT['purine nucleoside binding']
59: regulation of T cell activation, plasma membrane, INT['purine nucleoside binding']
60: lymphocyte differentiation, plasma membrane, INT['receptor binding']
61: regulation of lymphocyte activation, INT['protein phosphatase binding']
62: regulation of immune system process, membrane, INT['phosphoprotein binding']
63: positive regulation of immune system process, membrane, INT['phosphoprotein binding']
64: regulation of cell activation, membrane, INT['phosphoprotein binding']
65: leukocyte differentiation, membrane, INT['receptor signaling protein activity']
66: lymphocyte differentiation, INT['receptor signaling protein activity']
67: immune response, plasma membrane, INT['Antigen processing and presentation']
68: plasma membrane, INT['positive thymic T cell selection']
69: lymphocyte differentiation, INT['B cell receptor signaling pathway']
70: lymphocyte differentiation, INT['Renal cell carcinoma']
71: lymphocyte differentiation, INT['endomembrane system']
72: immune response, Antigen processing and presentation, INT['cytoplasmic part']
73: regulation of lymphocyte activation, INT['mitochondrial part']
74: regulation of T cell activation, membrane, INT['ErbB signaling pathway']
75: regulation of T cell activation, membrane, INT['Natural killer cell mediated cytotoxicity']
76: regulation of T cell activation, membrane, INT['B cell receptor signaling pathway']
77: regulation of T cell activation, membrane, INT['Fc gamma R-mediated phagocytosis']
78: regulation of T cell activation, plasma membrane, INT['Fc epsilon RI signaling pathway']
79: plasma membrane part, INT['positive T cell selection']
80: regulation of lymphocyte activation, INT['non-membrane spanning protein tyrosine kinase activity']
81: regulation of T cell activation, membrane, INT['purine nucleoside binding']
82: membrane part, Viral myocarditis, INT['receptor binding']
83: regulation of immune system process, plasma membrane, INT['phosphoprotein binding']
84: regulation of T cell activation, INT['phosphoprotein binding']
85: lymphocyte differentiation, INT['Natural killer cell mediated cytotoxicity']
86: lymphocyte differentiation, plasma membrane
87: lymphocyte differentiation, INT['external side of plasma membrane']
88: immune response, Allograft rejection
89: immune response, Cell adhesion molecules (CAMs), INT['intracellular membrane-bounded organelle']
90: antigen processing and presentation, integral to membrane
91: lymphocyte activation, membrane, INT['Hematopoietic cell lineage']
92: cell differentiation, INT['T cell receptor complex']
93: system development, INT['B cell receptor complex']
94: positive regulation of immune system process, membrane part, INT['B cell receptor signaling pathway']
95: positive regulation of immune system process, membrane part, INT['Fc gamma R-mediated phagocytosis']
96: regulation of lymphocyte activation, membrane part, INT['Chemokine signaling pathway']
97: regulation of lymphocyte activation, plasma membrane, INT['ErbB signaling pathway']
98: regulation of lymphocyte activation, INT['dendrite']
99: regulation of T cell activation, INT['Fc gamma R-mediated phagocytosis']
100: regulation of T cell activation, membrane, INT['Chemokine signaling pathway']
Figure 3 Comparison of SegMine and DAVID. The second part of the comparison of the results of SegMine and DAVID on the ALL dataset.
Columns are terms found to be enriched by DAVID, while rows are rules of terms found to be enriched by SegMine. The second half of the 100
rules of terms obtained by SegMine is shown. All results are statistically significant with p ≤ 0.05. Darker red shades of matrix cells indicate
higher overlapping of corresponding gene sets. Note that rows of the matrix that consist of lightly shaded cells represent gene sets identified as
significantly enriched by SegMine but not by DAVID, e.g., 57, 61, 73, 80, 84, and 98.
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Page 7 of 16degree of cellular aging in MSC are still not known or
explained. However, the increasing use of MSC as cellu-
lar therapeutics necessitates standardized isolation and
reliable quality control assessment of cell preparations.
Therefore, we focused on the analysis of a dataset where
gene expression profiles from late senescent passages of
MSC from three independent donors were compared to
the MSC of early passages [30]. We were able to formu-
late three novel research hypotheses that could improve
understanding of mechanisms in senescence and identi-
fication of candidate marker genes. One of our hypoth-
eses, derived from the 2008 dataset, may even
substantiate a recent proposition independently derived
from additional senescence gene expression data [30,40]
in 2010. Even though the hypotheses still need to be
verified by additional laboratory experiments these
results confirm that SegMine is a very useful tool for
exploratory analysis of gene expression data and formu-
lation of new research hypotheses.
Several analyses of microarray data from senescent
cells have already been performed [30,40,41]. In these
analyses, the senescence candidate marker genes were
typically drawn from a list of top differentially expressed
genes, that is, their selection depended mainly on their
gene expression (logFC and p-values). In contrast, Seg-
Mine also considers functional properties, as well as
direct and indirect connections to related genes and
proteins. We have taken the following SegMine steps to
analyze the MSC data, published by Wagner et al. [30]:
1. all regulated genes that have absolute logFC values
lower than 0.3 were filtered out,
2. only SegMine rules with the corrected p-value p ≤
0.05 were considered,
3. hierarchical clustering of rules using Ward linkage
criteria was used to produce nine rule clusters (Fig-
ure 4),
4. several Biomine queries between the source (clus-
ters 1, 2, 3) and target (cluster 9) genes were
formulated,
5. the resulting Biomine subgraphs were thoroughly
inspected prior to focusing on (a) gene hubs (nodes
with a large number of edges) where the majority of
edges were of the type interacts with,a n d( b )outlier
genes, which are represented with nodes having few
edges with very low weights, or isolated nodes (see
Figures 5 and 6).
F i r s tw et u r n e da t t e n t i o nt ot h eg e n ee n r i c h m e n ta n d
clustering of rules (steps 2 and 3 above). Comparing
these to the originally published results [30], we noticed
that our results lack rules annotated with cytoskeletal
parts, vacuole or lysosome terms, which had a low num-
ber of genes annotated to them in the original study.
These compartments are obviously not recognized as
important by SegMine. On the other hand, SegMine
analysis revealed annotations that were strongly over-
represented in Wagner’s analysis. We believe that these
processes (cell cycle, DNA metabolism and chromatin
organization) are indeed crucial for senescence progres-
sion. Wagner’s group recently approached the same set
of senescence associated gene clusters [40] with an
improved analysis of additional senescence gene expres-
sion data. Similarly to the SegMine clusters, their recent
publication does not mention the above unimportant
compartments that appeared in [30].
The nine clusters of rules produced in step 3 were
further analyzed to find links between distant clusters
(step 4 above). In particular, Biomine was queried to
discover links between genes from the source clusters 1-
3, and the genes of the target cluster 9, respectively.
Subgraphs, discovered by Biomine in step 5 were care-
fully inspected, and the following gene hubs were identi-
fied:
1. BRCA1 and SMAD2 genes from the cluster 1 vs.
cluster 9 query (Figure 5).
2. SMAD1, SMAD2 genes, and SMARCD1,
SMARCE1 genes from the cluster 2 vs. cluster 9
query.
3. MCM10 gene from the cluster 3 vs. cluster 9
query (Figure 6).
Four identified gene hubs (BRCA1 - breast cancer 1,
early onset; SMAD2 - SMAD family member 1;
SMARCD1 - SWI/SNF related, matrix associated, actin
dependent regulator of chromatin, subfamily D, member
1; and MCM10 - minichromosome maintenance com-
plex component 10) were evaluated for the presence of
direct links to previously published senescent candidate
marker genes. We found some of the senescent candi-
date marker genes, STAT1 [30], MCM3 [40], H2AFX,
AURKA [41], RAD50, and MRE11 [42], to be linked (by
the interacts with edge) to the BRCA1 gene hub (see
Figure 5). Likewise, MCM3 and MCM6 [41] were found
to be linked to the MCM10 gene hub (see Figure 6).
None of those already identified (patented) senescence
candidate marker genes could be recognized as a gene
hub by SegMine analysis, as they all had only a limited
number of direct links to other genes/proteins. More-
over, a published senescence candidate marker gene
SFPQ [41] was even identified as an outlier gene, with-
out any direct link with sufficiently high weight to be
present in the Biomine subgraph.
It can be hypothesized that the gene hubs (BRCA1,
MCM10, SMAD2, SMARC) identified by SegMine may
represent additional senescent candidate marker genes.
The results also show that the expression fold difference
Podpečan et al. BMC Bioinformatics 2011, 12:416
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Page 8 of 16'organelle organization', 'nuclear part', 'Cell cycle'
'organelle organization', 'nuclear part', 'chromatin binding'
'organelle organization', 'intracellular organelle part', 'chromatin binding'
'organelle organization', 'nucleus', 'chromatin binding'
'organelle organization', 'intracellular membrane-bounded organelle', 'chromatin binding'
'chromosome organization', 'nucleus', 'chromatin binding'
'organelle organization', 'heterochromatin'
'organelle organization', 'chromatin'
'chromosome organization', 'chromatin'
'chromosome organization', 'nuclear chromatin'
'organelle organization', 'chromosome, centromeric region'
'organelle organization', 'kinetochore'
'regulation of macromolecule metabolic process', 'intracellular non-membrane-bounded organelle', 'helicase activity'
'regulation of macromolecule biosynthetic process', 'regulation of cellular biosynthetic process', 'intracellular non-...
'chromosome', 'chromatin binding'
'nucleoside-triphosphatase activity', 'intracellular membrane-bounded organelle', 'post-translational protein modiﬁcation'
'organelle organization', 'nucleus', 'steroid hormone receptor binding'
'organelle organization', 'intracellular membrane-bounded organelle', 'steroid hormone receptor binding'
'organelle organization', 'intracellular organelle part', 'steroid hormone receptor binding'
'chromosome organization', 'nuclear part', 'transcription cofactor activity'
'chromosome organization', 'nuclear part', 'sequence-speciﬁc DNA binding'
'chromosome organization', 'intracellular organelle part', 'transcription coactivator activity'
'organelle organization', 'intracellular non-membrane-bounded organelle', 'transcription coactivator activity'
'organelle organization', 'intracellular non-membrane-bounded organelle', 'transcription cofactor activity'
'organelle organization', 'intracellular non-membrane-bounded organelle', 'transcription corepressor activity'
'organelle organization', 'nuclear lumen', 'transcription corepressor activity'
'organelle organization', 'nuclear part', 'transcription corepressor activity'
'organelle organization', 'nuclear lumen', 'transcription cofactor activity'
'organelle organization', 'nuclear part', 'transcription cofactor activity'
'nuclear part', 'chromatin assembly or disassembly'
'intracellular organelle part', 'chromatin assembly or disassembly'
'intracellular organelle part', 'protein-DNA complex assembly'
'nuclear part', 'protein-DNA complex assembly'
'intracellular non-membrane-bounded organelle', 'protein-DNA complex assembly'
'intracellular organelle part', 'DNA packaging'
'nucleus', 'protein-DNA complex assembly'
'intracellular membrane-bounded organelle', 'protein-DNA complex assembly'
'intracellular organelle', 'protein-DNA complex assembly'
'nucleoplasm', 'G1/S transition of mitotic cell cycle'
'nucleoplasm', 'Melanoma'
'nucleoplasm', 'Glioma'
'nuclear part', 'mitotic cell cycle checkpoint'
'nuclear part', 'G1/S transition checkpoint'
'nucleoplasm', 'cell cycle checkpoint'
'nucleoplasm', 'mitotic cell cycle checkpoint'
'nuclear lumen', 'regulation of S phase'
'intracellular organelle lumen', 'regulation of S phase'
'nuclear part', 'regulation of S phase'
'nucleoplasm', 'regulation of S phase'
'regulation of macromolecule metabolic process', 'nuclear part', 'Oocyte meiosis'
'regulation of macromolecule biosynthetic process', 'regulation of cellular biosynthetic process', 'nuclear part', 'Oocyte meiosis'
'regulation of macromolecule metabolic process', 'nuclear lumen', 'Oocyte meiosis'
'nucleoplasm', 'Oocyte meiosis'
'nuclear part', 'chromatin binding'
'nucleoplasm', 'chromatin binding'
'regulation of macromolecule biosynthetic process', 'regulation of cellular biosynthetic process', 'nuclear part', 'chromatin...
'cellular macromolecule metabolic process', 'nuclear part', 'chromatin binding'
'cellular macromolecule metabolic process', 'nuclear lumen', 'chromatin binding'
'nuclear part', 'DNA conformation change'
'cellular macromolecule metabolic process', 'intracellular non-membrane-bounded organelle', 'chromatin binding'
'macromolecule metabolic process', 'intracellular non-membrane-bounded organelle', 'chromatin binding'
'cellular response to stimulus', 'nuclear part', 'nuclear hormone receptor binding'
'cellular response to stimulus', 'intracellular organelle part', 'nuclear hormone receptor binding'
'cellular response to stimulus', 'intracellular organelle part', 'RNA binding'
'cellular response to stimulus', 'intracellular organelle', 'RNA binding'
'cellular macromolecule metabolic process', 'nuclear part', 'Glioma'
'macromolecule metabolic process', 'nuclear part', 'steroid hormone receptor binding'
'macromolecule metabolic process', 'nuclear part', 'androgen receptor binding'
'intracellular signaling cascade', 'chromosome, centromeric region'
'nuclear part', 'regulation of fatty acid metabolic process'
'nucleoplasm', 'negative regulation of organelle organization'
'RNA binding', 'microtubule cytoskeleton'
'DNA metabolic process', 'nucleus', 'RNA binding'
'DNA metabolic process', 'intracellular organelle part', 'RNA binding'
'DNA metabolic process', 'nuclear part', 'zinc ion binding'
'DNA metabolic process', 'intracellular organelle part', 'transition metal ion binding'
'DNA metabolic process', 'nucleus', 'chromatin binding'
'DNA metabolic process', 'nucleus', 'transcription coactivator activity'
'DNA metabolic process', 'intracellular organelle part', 'receptor binding'
'DNA metabolic process', 'nuclear part', 'transcription cofactor activity'
'DNA metabolic process', 'nuclear lumen', 'transcription factor binding'
'DNA metabolic process', 'nuclear part', 'transcription factor binding'
'DNA binding', 'nuclear lumen', 'mRNA processing'
'DNA binding', 'intracellular organelle part', 'mRNA processing'
'DNA binding', 'intracellular organelle part', 'RNA splicing'
'DNA binding', 'intracellular organelle lumen', 'mRNA metabolic process'
'DNA binding', 'organelle lumen', 'mRNA metabolic process'
'DNA binding', 'nuclear lumen', 'mRNA processing'
'DNA binding', 'intracellular organelle lumen', 'mRNA processing'
'DNA binding', 'nucleoplasm', 'mRNA metabolic process'
'DNA binding', 'nucleus', 'Spliceosome'
'DNA binding', 'intracellular non-membrane-bounded organelle', 'mRNA metabolic process'
'DNA binding', 'intracellular non-membrane-bounded organelle', 'RNA splicing'
'regulation of macromolecule biosynthetic process', 'regulation of cellular biosynthetic process', 'nuclear part', 'protein...
'regulation of transcription', 'nuclear part', 'protein domain speciﬁc binding'
'regulation of macromolecule biosynthetic process', 'regulation of cellular biosynthetic process', 'nuclear lumen', 'protein...
'regulation of macromolecule biosynthetic process', 'regulation of cellular biosynthetic process', 'nucleoplasm', 'protein...
'regulation of macromolecule metabolic process', 'nucleoplasm', 'protein domain speciﬁc binding'
'regulation of macromolecule metabolic process', 'nuclear part', 'protein domain speciﬁc binding'
'regulation of gene expression', 'nuclear part', 'protein domain speciﬁc binding'
Figure 4 Hierarchical clusters of rules for the MSC dataset. Hierarchical clustering of the top 100 statistically significant rules (p ≤ 0.05).
SegMine rules were obtained from a dataset of senescence in human mesenchymal stem cells (MSC dataset). Euclidean distance and Ward’s
linkage criteria were used to compute the hierarchy.
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Page 9 of 16of genes in gene hubs is not necessarily the highest. We
believe that even small expression changes in
SMARCD1, SMARCE1 and SMAD2 gene hubs may
nonetheless have quite a substantial impact on the pro-
cess of replicative senescence.
This assumption was confirmed by a literature survey
for biological functions of gene hubs identified by Seg-
Mine. MCMs, including our newly identified MCM10,
have long been known to regulate DNA synthesis by
replicative fork formation and to influence prolifera-
tion during cells’ progression toward senescence, when
their expression is switched off [43]. Even BRCA1, a
tumor suppressor notorious for its mutation-associated
development of certain types of tumors, was recently
found to be associated with replicative senescence. The
confirmed inactivation of the BRCA1 pathway in MSC
was found to reduce their long-term proliferation abil-
ity and increase senescence associated beta-galactosi-
dase activity [44]. This functional involvement of the
BRCA1/2 and RAD50/MRE11 in replicative senes-
cence, implicated first by Lansdorp [42], was now con-
firmed also by our SegMine analysis. Additionally,
SegMine identified SMADs gene hubs (signal transdu-
cers and transcriptional modulators), including
SMAD2, which has been known to mediate the TGFb
signalling pathway [45] involved in the long-term MSC
cultivation resulting in doubling time increase and
senescence. Besides senescence, SMADs involved in
the TGFb pathways were confirmed to regulate adipo-
genesis [45]. Similarly, potential involvement of
SMARCs genes in adipogenesis was confirmed by pro-
filing of mature differentiated adipocytes vs. prolifera-
tively active adipoblast [46].
A sac o n s e q u e n c e ,w eb e l i e v ethat our four identified
gene hubs may represent even better senescent gene
markers than the patented cell quality markers identified
solely by their high expression difference in senescent
cells and which were nevertheless found to be con-
nected to our gene hubs (note that only those gene
hubs that have edges of type interacts with with high
probabilities were selected and displayed). Furthermore,
SegMine allows visualization of links between genes,
enabling clear and easy identification of top processes
influencing cellular senescence. Lastly, least, the identifi-
cation of gene hubs, not necessarily the ones with high-
est differential expression, allowed us to formulate three
new hypotheses (which have yet to be confirmed in
future laboratory experiments).
Figure 5 A SegMine subgraph, where a strongly linked gene hub BRCA1 was identified. A part of the subgraph obtained by link search
between two clusters of rules describing differentially expressed gene sets. All genes covered by the rules from clusters 1 and 9 of hierarchical
clustering obtained from the MSC dataset were used. The subgraph allows for the Identification of BRCA1 and SMAD2 gene hubs. Some of the
senescent candidate marker genes such as STAT1, MCM3, H2AFX, AURKA, RAD50, MRE11 are linked to the identified BRCA1 gene hub.
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Page 10 of 16Hypothesis 1: Progression to senescence protects cells from
entering tumorigenic transition
This hypothesis is Wagner’s recent original proposition
substantiated with our SegMine results. It was proposed
[47] that a central pathway in senescence might provide
a purposeful program to protect the organism from
tumorigenesis by somatic cells that have accumulated
DNA mutations after a certain number of cell divisions.
We believe that an additional piece of evidence was
revealed to support this hypothesis. Besides the known
fact that senescence is not an inevitable fate for all cells,
we identified a novel senescence candidate marker gene,
the BRCA1 gene hub. The fact that BRCA1 has so far
been recognized mostly in tumor development provides
additional support for this hypothesis.
Hypothesis 2: The Low quality of adipose tissue derived
MSC is due to their enhanced tendency to senesce
This hypothesis speculates on a cause for the low quality
of adipose derived MSC reported by numerous labs
worldwide. Fat derived MSC cease to proliferate and
begin to senesce quite early, sometimes even
immediately after isolation. SMAD and SMARC gene
hubs, identified by SegMine, were all proven in the past
to be deregulated during adipogenic differentiation
[45,46]. Yet in our analysis they appear also to be over-
represented and deregulated in senescent cells; thus we
assume that genes of the senescence pathway are most
likely involved in adipose tissue homestasis as well. This
hypothesis would explain why MSC isolated from the
adipose tissue display enhanced permissiveness to senes-
cence upon isolation, as compared to MSC derived from
any other tissue.
Hypothesis 3: Autophagy may help cells to transiently
override their commitment to senesce
Several genes from intracellular protein trafficking and
autophagy (MAP1B, LYST, BECN1) were identified by
SegMine as outlier genes. When used in Biomine
queries they appeared in Biomine subgraphs as nodes
with no edges or with edges having very low weights,
meaning that knowledge about their links to other
genes/proteins is not readily available. However, as cells
use autophagy to overcome cell damage or nutrient
Figure 6 A SegMine subgraph with the MCM10 gene identified as a gene hub. A part of the subgraph obtained by link search between
two clusters of rules describing differentially expressed gene sets. All genes covered by the rules from clusters 3 and 9 of hierarchical clustering
obtained from the MSC dataset were used. The subgraph allows for the Identification of the MCM10 gene hub which is linked to MCM3 and
MCM6 senescent candidate marker genes.
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Page 11 of 16deprivation, this hypothesis is worth exploring, especially
in the light of the SEGS clustering, which on the basis
of gene-gene interactions already associated those genes
into clusters.
While the above three hypotheses will need to be
explored in laboratory experiments to validate their like-
lihood as contributing factors, the authors believe that
SegMine’s primary contribution is in providing a unique
exploratory environment that allows new hypotheses to
be formulated.
Implementation
In this section we discuss the implementation of the
workflow environment named Orange4WS, and the
implementation of the methodology itself. Note that the
presented implementation of the SegMine methodology
is only an example, as it can be implemented very differ-
ently in a different environment.
The Orange4WS data mining platform
The service-oriented data mining platform Orange4WS
is an easy-to-use software tool that enables creation and
execution of scientific workflows. It is built on top of
two open-source projects:
￿ the Orange data mining framework [26] and
￿ the Python Web Services project [48].
Orange provides a range of preprocessing, modeling,
and data exploration and visualization techniques as well
as a user-friendly workflow execution environment. The
Python Web Services project enables employment and
development of web services using the Python program-
ming language by implementing various protocols and
formats including XML [49], SOAP [50] and WSDL [51].
In contrast to other freely available data mining work-
flow environments such as Weka, Taverna, Triana,
KNIME and RapidMiner, the Orange4WS framework
offers a unique combination of features: (a) a large col-
lection of data mining and machine learning algorithms,
efficiently implemented in C++; (b) a three-layer archi-
tecture: C++, Python, and interactive workflows; (c) a
collection of very powerful yet easy-to-use data visuali-
zation components; (d) incorporation of propositional as
well as selected relational data mining algorithms, and
(e) simplicity of workflow composition.
As a result, Orange4WS provides a service-oriented
data mining software platform, ready to be used for any
task requiring data mining algorithms, web services,
workflows, complex visualization, rapid prototyping, and
other knowledge discovery scenarios. In comparison
with the well known Taverna workbench, Orange4WS
integrates a complete data mining environment
(Orange) with a wide range of machine and data mining
algorithms and visualization methods, as well as the
ability to use web services and rapid prototyping in
Python. Orange4WS offers a high level of abstraction
when composing workflows, which contributes to their
understandability and simplicity. Finally, Orange4WS
also integrates a general knowledge discovery ontology
and a planner enabling automated composition of data
mining workflows, although this topic is beyond the
scope of the work presented here, and therefore will not
be discussed. Finally, Orange4WS also enables auto-
mated composition of data mining workflows by inte-
grating a general knowledge discovery ontology and a
planner, although this topic is beyond the scope of the
work presented here, and therefore will not be
discussed.
Composition and execution of workflows
One of the most important features of Orange, also
inherited by Orange4WS, is an easy-to-use interactive
workflow construction that is supported by the Orange
Canvas, an interactive graphical user interface
component.
It enables graphical construction of workflows by
allowing interactive workflow elements called Orange
Widgets to be positioned in a desired order, connected
with lines representing flow of data, adjusted by setting
their parameters, and finally executed. For example, Fig-
ure 7 shows the Orange4WS environment running a
workflow of SegMine components (widgets).
The workflow management component enables or dis-
ables the connectivity of inputs and outputs according
to their types. It also prevents the user from creating
loops while connecting widgets by detecting cycles in
the corresponding directed graph. If a widget supports
the adjustment of its parameters, this can be done from
the widget’s user interface, which also enables data and
results visualization as well as other interactive features.
Finally, a constructed workflow can be saved into an
XML format that corresponds to a predefined XML
schema. This ensures repeatability of scientific experi-
ments as well as support for user collaboration.
Orange4WS offers support for SOAP as well as REST-
ful web services, which can be used as workflow compo-
nents. It provides modules that enable:
￿ loading web service consumer code,
￿ extracting information about web service input and
output data types,
￿ fully automatic creation of widgets (workflow com-
ponents) from web services, and
￿ support for creation of SOAP web services from
existing software and algorithm implementations.
When successfully imported, a web service can be
used as a normal Orange4WS widget. As a result,
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PubMed, the BioMart project [52], EMBL-EBI data
resources and analysis tools [53], life science web ser-
vices indexed by BioCatalogue [54], etc.
SegMine as Orange4WS workflows
We have implemented the SegMine methodology as a
collection of Orange4WS workflow components.
According to the four steps of the methodology these
components can be divided into four groups: (1) data
preprocessing, (2) identification of enriched gene sets,
( 3 )r u l ec l u s t e r i n g ,a n d( 4 )l i n kd i s c o v e r ya n d
visualization.
Data preprocessing
The following data preprocessing workflow components
(widgets) are available: loading of microarray data from
a text file, parsing of microarray data into an internal
versatile data structure used by Orange and Oran-
ge4WS, resolution of gene synonyms according to the
gene data provided by NCBI, ranking of genes using
ReliefF algorithm or t-test, loading of precomputed gene
ranks from a text file, plotting of gene ranks, and cutoff
of ranked genes according to the logFC values.
Identification of differentially expressed gene sets
Our SegMine implementation offers the following wid-
gets that enable and support identification of
differentially expressed gene sets: the SEGS algorithm
for different organisms (the current version supports
Homo sapiens, Mus musculus and Rattus norvegicus
experimental data by integrating corresponding anno-
tations to the ontologies), which is available as a fully
SOAP 1.1 compatible web service ready to be used in
any service-oriented software supporting SOAP web
services, e.g. The Taverna Workflow Management Sys-
tem; a rule browser component, which provides an
HTML table visualization where the results are linked
to the original data sources; construction of Orange’s
native data structure from the results of SEGS, which
enables the use of data mining techniques and algo-
rithms on the obtained enriched gene sets, and loading
and saving the results of SEGS into local files and
fetching the results from the server where the SEGS
web service is currently running.
Rule clustering
Clustering of SEGS rules is provided by the widget for
computing distances between rules using different
metrics, and the hierarchical clustering widget, which
provides different linkage criteria and supports interac-
tive cluster assignment and visualization (see Figure 4).
The rule browser component also links the rules to
their clusters and provides unions as well as intersec-
tions of gene sets in each cluster.
Figure 7 Orange4WS environment. A screenshot of Orange4WS running a workflow of SegMine components. The workflow exploits all four
main components of SegMine: loading and preprocessing the data, search for enriched gene sets, hierarchical clustering, and link discovery and
visualization. All available SegMine, as well as Orange4WS and Orange workflow components, are accessible by clicking on the corresponding
items in a tree view on the right.
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The presented implementation offers several compo-
nents that enable link discovery using Biomine services.
First, it provides widgets for neighborhood and connec-
tions search as well as search for medoids in a group of
genes, all of which query the Biomine web service using
the JSON protocol. Second, it integrates the Biomine
graph visualization component, which is run locally
from Orange4WS as a Java applet. Finally, it implements
widgets for adding information about gene expression
values, and for coloring selected nodes in Biomine
graphs.
Conclusions
This paper presents SegMine, a methodology for micro-
array data analysis combining cutting-edge data analysis
approaches, such as semantic data mining, link discov-
ery and visualization.
The methodology is implemented in reusable work-
flows within a new service-oriented data mining plat-
form, Orange4WS. Providing a novel approach to the
exploration of microarray datasets in the context of gen-
eral knowledge is a step beyond the existing state-of-
the-art transcriptomic analysis tools. The developed
platform is flexible, enabling easy adaptation to the
investigated dataset through different filtering options,
through different SEGS and Biomine settings, and
through different combinations of analysis and visualiza-
tion tools. The advanced options additionally enable
cross-domain link discovery, thus rendering the inter-
pretation of the biological mechanisms underlying dif-
ferential gene expression understandable to life
scientists.
Novel hypotheses, based on the SegMine analysis of
MSC microarray data, were presented. We confirmed
the strength of SegMine’s exploratory analysis, which
links the deregulated genes to other related genes/pro-
teins, and this was further supported by literature sur-
vey. We were able to formulate three novel research
hypotheses that improve understanding of the underly-
ing mechanisms in senescence and identification of can-
d i d a t em a r k e rg e n e s .T h i sm a yp a v et h ew a yt oa
reliable, functionally confirmed panel of senescence
marker genes, which can be used as molecular signa-
tures to distinguish between senescent and normal high
quality MSC. Such specification of senescence-associated
candidate marker genes, functionally evaluated and
cross-validated in different MSC preparations, may ulti-
mately result in more reliable quality control of cell pre-
parations, which are increasingly used in cell based
therapies.
In the future the presented work will be extended at
several levels. While the SegMine methodology is fairly
complete, it only provides means for the analysis of
genomics data; we plant to extend the methodology to
other types of omics data, such as proteomics and meta-
bolomics. The Biomine system currently employs only
basic text mining techniques, which will be improved
and complemented with natural language processing
tools in order to obtain more structured data from tex-
tual data sources such as open-access article databases.
The SegMine implementation in Orange4WS will be
extended with additional components such as visualiza-
tion of enriched ontology terms similar to the one pro-
v i d e db yt h eG O r i l l at o o l[ 5 5 ] .T h eO r a n g e 4 W S
workflow environment will also be subject to improve-
ments in order to adapt to the extensions of the metho-
dology, and to improve the support for the publicly
available systems biology web services and data and
knowledge sources.
Availability
The Orange4WS platform is available at http://oran-
ge4ws.ijs.si.
Our reference implementation of the SegMine metho-
dology for Orange4WS is available at http://segmine.ijs.
si.
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